Results 321 to 330 of about 690,694 (375)

Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond

Genes, Chromosomes and Cancer, 2020
Uterine leiomyoma and leiomyosarcoma are located at the ends of the spectrum of smooth muscle lesions. Leiomyosarcoma belongs to the complex genomic sarcomas characterized by complex karyotypes.
S. Croce, F. Chibon
semanticscholar   +1 more source

Postirradiation malignant neoplasms of the uterine fundus

American Journal of Obstetrics and Gynecology, 1969
Abstract These neoplasms are a rather rare complication occurring some years following irradiation of the uterus for either benign conditions or for carcinoma of the cervix. Sixteen cases are reported, of which 11 were adenocarcinoma of the endometrium, 3 were carcinosarcoma, and 2 were mixed mesodermal tumors of the uterus.
James A. Enden, Homer H. Harris, William O. Thomas   +2 more
openaire   +4 more sources

73. Uterine neoplasm as a cause of prepubertal bleeding

Journal of Pediatric and Adolescent Gynecology, 2021
Background Vaginal bleeding in the prepubertal child has several etiologies including structural anomalies, endocrinologic dysfunction, infection, trauma, foreign body, and hematologic disorders. While bleeding in this age group is often benign, it can be distressing to both the child and parent so a comprehensive evaluation is important.
Jessica Shim, Marc R. Laufer, Anam Khaja
openaire   +2 more sources

Recent developments in uterine mesenchymal neoplasms

Histopathology, 2012
Smooth muscle and endometrial stromal tumours represent the two most common uterine mesenchymal neoplasms that may present diagnostic dilemmas for the practising surgical pathologist. Recent changes in morphological and staging criteria, as well as the discovery of new immunohistochemical markers, have improved the diagnosis and classification of these
Esther Oliva, Sarah Chiang
openaire   +3 more sources

Update on SWI/SNF‐related gynecologic mesenchymal neoplasms: SMARCA4‐deficient uterine sarcoma and SMARCB1‐deficient vulvar neoplasms

Genes, Chromosomes and Cancer, 2020
Our knowledge regarding the role of genes encoding the chromatin remodeling switch/sucrose non‐fermenting (SWI/SNF) complex in the initiation and progression of gynecologic malignancies continues to evolve.
B. Howitt, A. Folpe
semanticscholar   +1 more source

p53 Expression in Neoplasms of the Uterine Corpus

American Journal of Clinical Pathology, 1992
It has been recognized that mutations in tumor suppressor genes may have an important oncogenic role. Although abnormalities of the p53 tumor suppressor gene have been reported in tumors from various organ systems, p53 expression has not been studied in neoplasms of the uterine corpus.
Lisa Edelmann, Martin E. Bur, Edward G. Fey, Peter G. Rose, Claire Perlman   +4 more
openaire   +3 more sources

Role of the Immunohistochemical ZEB1 Expression in Uterine Mesenchymal Neoplasms

International Journal of Surgical Pathology, 2022
The distinction of mesenchymal tumors of the uterus is a frequent diagnostic challenge in gynecologic pathology. Especially, distinguishing low-grade endometrial stromal sarcoma (ESS) from leiomyoma or distinguishing low-grade ESS from high-grade ESS can be difficult.
Murat Çelik, Zeliha Esin Çelik
openaire   +2 more sources

Mast cells in uterine myometrium and leiomyomatous neoplasms

American Journal of Obstetrics and Gynecology, 1965
Abstract The numbers of mast cells were found to be fairly constant in the myometrium of the corpora uteri, and not to vary significantly with age or phase of the menstrual cycle. Reduced numbers of mast cells were present in gravid uteri. Considerable variation in numbers of mast cells occurred in the leiomyomatous tumors but the average counts ...
James E. Fox, Murray R. Abell
openaire   +3 more sources

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.

The Journal of the National Comprehensive Cancer Network
The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer and uterine sarcoma.
N. Abu-Rustum, Susan M. Campos, Sudha Amarnath, Rebecca Arend, Emma Barber, Kristin Bradley, Rebecca Brooks, Junzo Chino, H. Chon, M. Crispens, Shari Damast, Christine M. Fisher, Peter Frederick, David K. Gaffney, Stephanie Gaillard, Robert Giuntoli, Scott Glaser, Brooke E Howitt, Lisa Landrum, Jayanthi Lea, Nita Lee, G. Mantia-Smaldone, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Karina Nieto, Chika Nwachukwu, Mirna Podoll, Kerry Rodabaugh, Ritu Salani, John Schorge, Scott Schuetze, Jean Siedel, Rachel Sisodia, Pamela Soliman, Stefanie Ueda, Renata Urban, E. Wyse, Nicole R Mcmillian, Vaishnavi Sambandam   +40 more
semanticscholar   +1 more source

Adenomyoma mimicking an aggressive uterine neoplasm on MRI

The British Journal of Radiology, 2003
This case report concerns a nulliparous female with prolonged vaginal bleeding, where MRI demonstrated a mass with an aggressive, tumour like appearance involving the posterior aspect of the uterus. Histological examination confirmed that this was an adenomyoma. The unusual imaging appearance of this lesion and its differential diagnosis are discussed.
A M Connors, N M deSouza, G A McIndoe
openaire   +3 more sources